Ftse Mib
37.710,96
0,48%
DAX
22.495,00
1,59%
S&P 500
6.051,97
-0,27%
NASDAQ
19.649,95
0,03%
Bitcoin
95.818,87
-2,12%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Biomerica Inc (BMRA) Biomerica Inc (BMRA) Notizie

Biomerica Inc

BMRA
0,6699
-0,0261 (-3,75%)
Pre Mercato
Ultimo aggiornamento: 12:57:30
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/2/202522:32EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
16/1/202514:19GLOBEUnited Arab Emirates Ministry of Health and Prevention..
15/1/202514:19GLOBEBiomerica Reports Second Quarter Fiscal 2025 Financial..
14/1/202523:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
20/12/202423:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
18/12/202401:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202401:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202401:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202401:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202423:00EDGAR2Form 8-K - Current report
25/11/202423:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/11/202414:19GLOBEBiomerica Secures Three Key International Patents for..
14/11/202422:19EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202415:09GLOBENasdaq grants Biomerica an additional 180 days to meet..
06/11/202423:20EDGAR2Form 8-K - Current report
30/10/202413:19GLOBEBiomerica Announces Direct-to-Consumer Availability of..
16/10/202415:00GLOBEBiomerica Reports First Quarter Fiscal 2025 Financial..
15/10/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/9/202423:00EDGAR2Form DEF 14A - Other definitive proxy statements
20/9/202423:00EDGAR2Form PRE 14A - Other preliminary proxy statements
04/9/202414:19GLOBEThe Saudi Food and Drug Authority (SFDA) Approves..
29/8/202415:00GLOBEBiomerica Reports Fiscal 2024 Year End Results
28/8/202423:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/7/202413:47GLOBEBiomerica Launches At-Home Sample Collection for inFoods®..
13/5/202414:19GLOBEBiomerica Announces inFoods® IBS Pilot Launch with Prominent..
10/5/202423:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/5/202423:15EDGAR2Form 8-K - Current report
29/4/202414:19GLOBEBiomerica and Leading UAE Healthcare Company Forge a Path to..
15/4/202413:47GLOBEBiomerica provides update on inFoods® IBS expansion
13/4/202401:23GLOBEBiomerica Reports Third Quarter 2024 Financial Results
28/3/202413:19GLOBEBiomerica InFoods IBS Data to be Presented at the Upcoming..
21/2/202414:19GLOBEDiagnostics Industry Leader Gary Huff Appointed to Biomerica..
14/2/202415:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
Apertura: Min: Max:
Chiusura: 0,696

La tua Cronologia

NASDAQ
BMRA
Biomerica
LSE
LTG
Learning Technologies
USOTC
INCC
International Consolidat... (PK)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci